Top Growth Driver In The Praluent Market 2025: Increasing Cardiovascular Disease Drive Market Growth
What Lies Ahead for Praluent? Projections indicate that the Praluent market will continue its upward trajectory in the coming years: .Market Value Forecast: Expected to reach $XX million by 2029.
Fintel on MSN19h
Needham Initiates Coverage of Ocular Therapeutix (OCUL) with Buy Recommendation
Fintel reports that on March 11, 2025, Needham initiated coverage of Ocular Therapeutix (NasdaqGM:OCUL) with a Buy ...
Ocular rises as Needham issues new Buy on lead candidate
Ocular Therapeutix (NASDAQ:OCUL) stock rises as Needham rates the company a new Buy, citing the potential of its lead candidate, Axpaxli. Read more here.
European Medical Journal15h
Nemolizumab in Moderate-to-Severe Atopic Dermatitis: Long-Term Safety and Efficacy and New Biomarker Insights
Guttman-Yassky received research support, consulting, or lecture fees on atopic dermatitis from Regeneron, Sanofi, Pfizer, ...